A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression. Researchers tracked changes in a critical brain receptor ...

Researchers used a novel PET tracer to visualize how ketamine alters AMPA receptor distribution in the brains of patients ...

Researchers from Japan have uncovered direct evidence showing how ketamine exerts its rapid antidepressant effects in ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...

Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image ...

Major depressive disorder (MDD) is a major global health problem and one of the leading causes of disability. About 30% of people diagnosed with ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

A team of Korean researchers has, for the first time, developed a technology capable of enabling early diagnosis of major ...

For people antidepressants can’t help, ketamine changes the brain in ways we can now see In A Nutshell For the first time, researchers used a specialized brain scan to watch how ketamine alters a key ...

United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, showcased its comprehensive innovation portfolio at ECR 2026 with the ...